Alumni raised $1.45B in 2022 - Download Free Report Now

OptiScan Biomedical

An automated, continuous glucose monitor for bedside use in intensive and critical care.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of OptiScan Biomedical plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About OptiScan Biomedical

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

Competing Startups


Companies We Work With